Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form
As of April 1st VIVO Scientific Profiles will no longer updated for faculty, and the link to VIVO will be removed from the library website. Faculty profile pages will continue to be updated via Interfolio. VIVO will continue being used behind the scenes to update graduate student profiles. Please contact helplib@scripps.edu if you have questions.
How to download citations from VIVO | Alternative profile options

An engineered selenocysteine defines a unique class of antibody derivatives

Academic Article
uri icon
  • Overview
  • Research
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Hofer, T.
  • Thomas, J. D.
  • Burke, T. R.
  • Rader, Christoph

publication date

  • August 2008

journal

  • Proceedings of the National Academy of Sciences of the United States of America  Journal

abstract

  • Selenocysteine is cotranslationally inserted into proteins by recoding the stop codon UGA from termination to selenocysteine insertion. The nucleophilic selenol group of selenocysteine endows this rare amino acid with unique chemical reactivity that allows regiospecific covalent conjugation in the presence of the other natural amino acids. Using a mammalian expression system, we generated an IgG1-derived Fc fragment with a C-terminal selenocysteine in yields comparable to conventional monoclonal antibodies and conjugated it to an electrophilic derivative of a peptidomimetic that binds with high affinity and specificity to integrin alpha(4)beta(1). Through this conjugation, both the biological and chemical components are endowed with pharmacological advantages. We demonstrate that whereas the Fc protein increases the circulatory half-life from minutes to days and mediates transcytosis through binding to the neonatal Fc receptor, the peptidomimetic introduces cross-species binding to cell surface integrin alpha(4)beta(1) and blocks its interaction with vascular cell adhesion molecule-1. Compared with conventional monoclonal antibodies, our technology benefits economically from combining a generic biological component with a variable chemical component.

subject areas

  • Antibodies
  • Codon, Terminator
  • Endocytosis
  • Half-Life
  • Humans
  • Immunoglobulin Fc Fragments
  • Immunoglobulin G
  • Integrin alpha4beta1
  • Protein Biosynthesis
  • Protein Engineering
  • Receptors, Fc
  • Selenocysteine
scroll to property group menus

Research

keywords

  • Fc fragment
  • antibody engineering
  • integrin alpha(4)beta(1)
  • neonatal Fc receptor
  • small synthetic molecules
scroll to property group menus

Identity

PubMed Central ID

  • PMC2518826

International Standard Serial Number (ISSN)

  • 0027-8424

Digital Object Identifier (DOI)

  • 10.1073/pnas.0800800105

PubMed ID

  • 18719095
scroll to property group menus

Additional Document Info

start page

  • 12451

end page

  • 12456

volume

  • 105

issue

  • 34

©2022 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support